Marshall Wace LLP acquired a new stake in ICU Medical, Incorporated (NASDAQ:ICUI) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 153,260 shares of the medical instruments supplier’s stock, valued at approximately $43,334,000.
Other large investors also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of ICU Medical by 12.0% during the third quarter. Vanguard Group Inc. now owns 1,483,501 shares of the medical instruments supplier’s stock valued at $419,459,000 after acquiring an additional 158,798 shares during the last quarter. BlackRock Inc. increased its position in shares of ICU Medical by 8.3% during the third quarter. BlackRock Inc. now owns 1,431,253 shares of the medical instruments supplier’s stock worth $404,685,000 after buying an additional 109,396 shares during the period. Janus Henderson Group PLC increased its position in shares of ICU Medical by 0.5% during the third quarter. Janus Henderson Group PLC now owns 1,370,845 shares of the medical instruments supplier’s stock worth $387,606,000 after buying an additional 7,475 shares during the period. Wells Fargo & Company MN increased its position in shares of ICU Medical by 15.6% during the third quarter. Wells Fargo & Company MN now owns 507,855 shares of the medical instruments supplier’s stock worth $143,595,000 after buying an additional 68,347 shares during the period. Finally, AQR Capital Management LLC increased its position in shares of ICU Medical by 566.3% during the third quarter. AQR Capital Management LLC now owns 382,179 shares of the medical instruments supplier’s stock worth $108,061,000 after buying an additional 324,819 shares during the period. 75.97% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $297.00 price objective for the company in a research report on Thursday, November 1st. ValuEngine upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. BidaskClub cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 8th. Finally, TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th.
In other ICU Medical news, Director Pfizer Inc sold 2,500,000 shares of the firm’s stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $209.25, for a total value of $523,125,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 12.50% of the company’s stock.
NASDAQ:ICUI traded down $2.71 during trading hours on Friday, reaching $235.54. The company had a trading volume of 1,844 shares, compared to its average volume of 350,628. The stock has a market capitalization of $4.89 billion, a price-to-earnings ratio of 42.71 and a beta of 0.62. ICU Medical, Incorporated has a twelve month low of $205.55 and a twelve month high of $321.70.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.34. The business had revenue of $327.20 million during the quarter, compared to analysts’ expectations of $334.97 million. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The business’s quarterly revenue was down 4.7% on a year-over-year basis. During the same period last year, the company posted $1.12 earnings per share. On average, research analysts forecast that ICU Medical, Incorporated will post 7.76 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Marshall Wace LLP Acquires Shares of 153,260 ICU Medical, Incorporated (ICUI)” was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://transcriptdaily.com/2018/12/07/marshall-wace-llp-acquires-shares-of-153260-icu-medical-incorporated-icui.html.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: Terms to Better Understand Call Options
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.